Tiansheng Pharmaceutical Group Co., Ltd. (002872.SZ)
CNY 4.76
(-0.83%)
CNY 4.76
(-0.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 579.33 Million | 606.99 Million | 736.68 Million | 1.2 Billion | 1.67 Billion | 2.17 Billion |
| Cost of Revenue | 322.36 Million | 263.59 Million | 432.7 Million | 852.83 Million | 1.2 Billion | 1.54 Billion |
| Gross Profit | 256.97 Million | 343.39 Million | 303.98 Million | 349.91 Million | 472 Million | 622.85 Million |
| Operating Expenses | 350.54 Million | 407.8 Million | 337.36 Million | 445.65 Million | 573.83 Million | 505.71 Million |
| Selling, General and Administrative Expenses | 213.24 Million | 303.04 Million | 260.78 Million | 351.81 Million | 454.63 Million | 399.46 Million |
| Research and Development Expenses | 30.91 Million | 34.26 Million | 29.24 Million | 22.45 Million | 36.28 Million | 39.78 Million |
| Other Expenses | 3.17 Million | 70.49 Million | 47.34 Million | 71.37 Million | 82.91 Million | 66.47 Million |
| Cost and Expenses | 672.9 Million | 671.4 Million | 770.07 Million | 1.29 Billion | 1.77 Billion | 2.05 Billion |
| Operating Income | -93.57 Million | -51.19 Million | -6.51 Million | -95.73 Million | -102.65 Million | 96.62 Million |
| Interest Expense | 14.99 Million | 15.78 Million | 24.35 Million | 38.88 Million | 37.64 Million | 42.18 Million |
| Income Tax Expense | -1.01 Million | 7.43 Million | 17.89 Million | -40.99 Million | -10.69 Million | 21.42 Million |
| Earnings before Tax | -94.72 Million | -84.11 Million | -54.44 Million | -534.57 Million | -229.63 Million | 37.04 Million |
| Net Income | -93.07 Million | -91.55 Million | -72.33 Million | -493.58 Million | -218.93 Million | 15.62 Million |
| Earnings Per Share Basic | -0.29 | -0.29 | -0.23 | -1.55 | -0.69 | 0.06 |
| Earnings Per Share Diluted | -0.29 | -0.29 | -0.23 | -1.55 | -0.69 | 0.06 |
| Weighted Average Shares Outstanding | 318 Million | 318 Million | 318 Million | 318 Million | 318 Million | 247.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 318 Million | 318 Million | 318 Million | 318 Million | 318 Million | 247.5 Million |
| Gross Margin | 0.44 | 0.57 | 0.41 | 0.29 | 0.28 | 0.29 |
| EBIT Margin | 0.05 | 0.09 | 0.11 | -0.01 | 0.00 | 0.09 |
| Profit Margin | -0.16 | -0.15 | -0.10 | -0.41 | -0.13 | 0.01 |
| EBITDA | 29.13 Million | 39.31 Million | 59.9 Million | -370.22 Million | -82.27 Million | 187.72 Million |
| Earnings Before Tax Margin | -0.16 | -0.08 | -0.01 | -0.08 | -0.06 | 0.04 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 118.16 Million | 129.56 Million | 145.37 Million | 172.94 Million | 579.33 Million | 113.06 Million |
| Cost of Revenue | 66.95 Million | 88.62 Million | 80.69 Million | 83.72 Million | 306.56 Million | 70.39 Million |
| Gross Profit | 51.2 Million | 40.93 Million | 64.68 Million | 89.21 Million | 272.76 Million | 42.67 Million |
| Operating Expenses | 62.6 Million | 65.55 Million | 89.96 Million | 82.19 Million | 337.33 Million | 69.24 Million |
| Selling, General and Administrative Expenses | 56.39 Million | 54.66 Million | 83.97 Million | -26.71 Million | - | 112.86 Million |
| Research and Development Expenses | 5.92 Million | 7.15 Million | 5.77 Million | 8.82 Million | - | 6.6 Million |
| Other Expenses | -290.25 Thousand | -3.73 Million | -209.43 Thousand | 2.97 Million | -1.15 Million | -4.85 Million |
| Cost and Expenses | 129.56 Million | 154.18 Million | 170.65 Million | 165.92 Million | 643.9 Million | 139.63 Million |
| Operating Income | -11.4 Million | -24.61 Million | -25.27 Million | -9.39 Million | -93.57 Million | -29.02 Million |
| Interest Expense | 4.24 Million | 4.49 Million | 3.34 Million | 3.24 Million | 14.99 Million | 4.5 Million |
| Income Tax Expense | 1.62 Million | -943.75 Thousand | -2.49 Million | 5.09 Million | -1.01 Million | -2.78 Million |
| Earnings before Tax | 9.98 Million | -22.07 Million | -23.25 Million | -6.42 Million | -94.72 Million | -33.88 Million |
| Net Income | 6.75 Million | -22.64 Million | -20.46 Million | -11.24 Million | -93.07 Million | -31.04 Million |
| Earnings Per Share Basic | 0.02 | -0.07 | -0.06 | -0.04 | - | -0.10 |
| Earnings Per Share Diluted | 0.02 | -0.07 | -0.06 | -0.04 | - | -0.10 |
| Weighted Average Shares Outstanding | 318 Million | 318 Million | 318 Million | 317.99 Million | 317.98 Million | 318 Million |
| Weighted Average Shares Outstanding (Diluted) | 318 Million | 318 Million | 318 Million | 317.99 Million | 317.98 Million | 318 Million |
| Gross Margin | 0.43 | 0.32 | 0.44 | 0.52 | 0.47 | 0.38 |
| EBIT Margin | 0.12 | 0.03 | -0.13 | 0.08 | - | -0.26 |
| Profit Margin | 0.06 | -0.17 | -0.14 | -0.07 | -0.16 | -0.27 |
| EBITDA | 14.23 Million | 3.28 Million | -18.69 Million | 13.74 Million | - | -29.56 Million |
| Earnings Before Tax Margin | -0.10 | -0.19 | -0.17 | -0.05 | -0.16 | -0.26 |
R35
HNL
AOMD
600968
ELECTHERM
MARK